With a focus on combating hyperuricemia, Loncom Pharma's Anti Gout APIs, including innovative compounds like Topiroxostat and Febuxostat, are essential for creating medications that manage gout and its complications. These APIs inhibit xanthine oxidase, the enzyme responsible for uric acid production, thereby providing relief and prevention of gout attacks.
